Amniotic fluid soluble fas levels in intra-amniotic infection

Obstetrics and Gynecology

Volumn 95, Issue 5, 2000, Pages 667-670

  Hsu, Chaur Dong ^a   Hong, Shih Feng ^a   Harirah, Hassan ^a   Bahado Singh, Ray ^a   Lu, Li Cheng ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FAS ANTIGEN;

ADOLESCENT; ADULT; AMNIOCENTESIS; AMNIONITIS; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHORIOAMNIONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; PATHOGENESIS; PRIORITY JOURNAL; SEPTICEMIA;

ADOLESCENT; ADULT; AMNIOTIC FLUID; ANTIGENS, CD95; BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; CHORIOAMNIONITIS; FEMALE; HUMANS; MYCOSES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0034077613     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00664-X     Document Type: Article

References (17)

1. Gibbs R.S., Castillo M.S., Rogers P.J. Management of acute chorioamnionitis. Am J Obstet Gynecol. 136:1980;709-713.
2. Hauth J.C., Gilstrap L.C., Hankins G.D.V., Connor K.D. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol. 66:1985;59-62.
3. Romero R., Sirtori M., Oyarzun E., Avila C., Mazor M., Callaham R., et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intra-amniotic infection. Am J Obstet Gynecol. 161:1989;817-824.
4. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.I., Sameshima M., et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
5. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol. 148:1992;1274-1279.
6. Nagata S., Goldstein P. The Fas death factor. Science. 267:1995;1449-1456.
7. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
8. Knipping E., Krammer P.H., Onel K.B., Lehman T.J., Mysler E., Elkon K.B. Soluble Fas/APO1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis. Arthritis Rheum. 38:1995;1735-1737.
9. Midis G.P., Shen Y., Owen-Schaub L.B. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Res. 56:1996;3870-3874.
10. Taieb J., Mathurin P., Poynard T., Gougerot-Pocidalo M.A., Chollet-Martin S. Raised plasma soluble Fas and Fas ligand in alcoholic liver disease. Lancet. 351:1998;1930-1931.
11. Okuyama M., Yamaguchi S., Nozaki N., Yamaoka M., Shirakabe M., Tomoike H. Serum levels of soluble form of Fas molecule in patients with congestive heart failure. Am J Cardiol. 79:1997;1698-1701.
12. Kamihira S., Yamada Y., Hiragata Y., Yamaguchi T., Izumikawa K., Matsuo Y., et al. Serum levels of soluble Fas/APO-1 receptor in human retroviral infection and associated diseases. Intern Med. 36:1997;166-170.
13. Muner R., Midis G., Owen-Schaub L., Andreff M. Soluble Fas (CD95) is not elevated in the serum of patients with myeloid leukemias, myeloproliferative and myelodysplastic syndromes. Leukemia. 10:1996;1531-1533.
14. Runic R., Lockwood C.J., LaChapelle L., Dipasquale B., Demopoulos R.I., Kumar A., et al. Apoptosis and Fas expression in human fetal membranes. J Clin Endocrinol Metab. 83:1998;660-666.
15. Cascino I., Fiucci G., Papoff G., Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol. 154:1995;2706-2713.
16. Papoff G., Cascino I., Eramo A., Starace G., Lynch D.H., Ruberti G. An N-terminal domain shared by Fas/APO-1 (CD95) soluble variants prevent cell death in vitro. J Immunol. 156:1996;4622-4630.
17. Knipping E., Debatin K.M., Stricker K., Heilig B., Eder A., Krammer P.H. Identification of soluble APO-1 in supernatants of human leukemias. Blood. 85:1995;1562-1569.